A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

NCT00631124 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: BAY86-4891 (Estradiol / Drospirenone)
DRUG: BAY86-4891 (Estradiol / Drospirenone)

Sponsor

Bayer